In addition, since elevated CA125 levels can occur in various benign gynecologic conditions and other disease states, such as leiomyoma and endometriosis, elevated CA125 may not be an ideal serum biomarker in premenopausal patients. This evidence concerns the gene MUC16 and endometriosis.